A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleA Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsSungha Park